Suppr超能文献

表面活性剂介导的精确尺寸脂质体组装。

Surfactant-Mediated Assembly of Precision-Size Liposomes.

作者信息

Pires Ivan S, Suggs Jack R, Carlo Isabella S, Yun DongSoo, Hammond Paula T, Irvine Darrell J

机构信息

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, Massachusetts 02139, United States.

Department of Chemical Engineering, Massachusetts Institute of Technology, 21 Ames Street, Cambridge, Massachusetts 02139, United States.

出版信息

Chem Mater. 2024 Jul 25;36(15):7263-7273. doi: 10.1021/acs.chemmater.4c01127. eCollection 2024 Aug 13.

Abstract

Liposomes can greatly improve the pharmacokinetics of therapeutic agents due to their ability to encapsulate drugs and accumulate in target tissues. Considerable effort has been focused on methods to synthesize these nanocarriers in the past decades. However, most methods fail to controllably generate lipid vesicles at specific sizes and with low polydispersity, especially via scalable approaches suitable for clinical product manufacturing. Here, we report a surfactant-assisted liposome assembly method enabling the precise production of monodisperse liposomes with diameters ranging from 50 nm to 1 μm. To overcome scalability limitations, we used tangential flow filtration, a scalable size-based separation technique, to readily concentrate and purify the liposomal samples from more than 99.9% of detergent. Further, we propose two modes of liposome self-assembly following detergent dilution to explain the wide range of liposome size control, one in which phase separation into lipid-rich and detergent-rich phases drives the formation of large bilayer liposomes and a second where the rate of detergent monomer partitioning into solution controls bilayer leaflet imbalances that promote fusion into larger vesicles. We demonstrate the utility of controlled size assembly of liposomes by evaluating nanoparticle uptake in macrophages, where we observe a clear linear relationship between vesicle size and total nanoparticle uptake.

摘要

由于脂质体能够包封药物并在靶组织中蓄积,因此它们可以极大地改善治疗剂的药代动力学。在过去几十年中,大量的努力都集中在合成这些纳米载体的方法上。然而,大多数方法无法可控地生成特定尺寸且低多分散性的脂质囊泡,特别是通过适用于临床产品制造的可扩展方法。在此,我们报道了一种表面活性剂辅助的脂质体组装方法,该方法能够精确生产直径范围从50纳米到1微米的单分散脂质体。为了克服可扩展性限制,我们使用切向流过滤(一种基于尺寸的可扩展分离技术),从超过99.9%的去污剂中轻松浓缩和纯化脂质体样品。此外,我们提出了去污剂稀释后脂质体自组装的两种模式,以解释脂质体尺寸控制的广泛范围,一种是相分离成富含脂质和富含去污剂的相驱动大双层脂质体的形成,另一种是去污剂单体分配到溶液中的速率控制双层小叶失衡,促进融合成更大的囊泡。我们通过评估巨噬细胞对纳米颗粒的摄取来证明脂质体可控尺寸组装的实用性,在那里我们观察到囊泡大小与纳米颗粒总摄取量之间存在明显的线性关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8100/11325547/eabe31578008/cm4c01127_0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验